QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=37D5330E288703DFF7CC517C6E8509B3;jsessionid=58A672A1EA4C14F7885F87150B4FA23E;jsessionid=BA006330F0CB3A4E725D3BC07DD0739A;jsessionid=66A2BB7F1DB5761E1E056D6811945BD7;jsessionid=892E6F7ED91AAE060C74674D88F085A6 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
3. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
4. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
5. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=37D5330E288703DFF7CC517C6E8509B3;jsessionid=58A672A1EA4C14F7885F87150B4FA23E;jsessionid=BA006330F0CB3A4E725D3BC07DD0739A;jsessionid=66A2BB7F1DB5761E1E056D6811945BD7;jsessionid=892E6F7ED91AAE060C74674D88F085A6